Treatment of poor prognosis non-Hodgkin's lymphoma using cyclophosphamide and total body irradiation regimens with autologous bone marrow rescue.
Twenty patients with poor prognosis non-Hodgkin's lymphoma received regimens which employed cyclophosphamide and total body irradiation followed by autologous bone marrow rescue. There were two toxic deaths. All 10 patients with residual disease prior to treatment achieved a complete remission. Ten patients survive disease free from 1.4 to 9.5 years and median survival exceeds 2.9 years. The actuarial 3-year disease-free survival is 50%. Treatment with cyclophosphamide and total body irradiation followed by autologous bone marrow infusion is an effective salvage regimen for poor prognosis lymphoma. Durable long-term remissions can be achieved.
Braine
H G
HG
Bone Marrow Transplantation Program, Johns Hopkins Oncology Center, Baltimore, MD 21205.
Santos
G W
GW
Kaizer
H
H
Yeager
A M
AM
Mann
R B
RB
Burns
W H
WH
Civin
C I
CI
Fuller
D J
DJ
Rowley
S D
SD
Saral
R
R
D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D011379:Prognosis; D014916:Whole-Body Irradiation
D003520:Cyclophosphamide